Pandora Report 11.16.2026: Future-Proofing Biosecurity – ELBI 2026, Pacific Northwest H5N1 & Global Weapons Norms

Welcome to this week’s Pandora Report! This issue highlights the next generation of global biosecurity leaders, the evolving H5N1 outbreaks in the Pacific Northwest, and international efforts to strengthen chemical and biological weapons norms.


📣 Interested in Graduate Study in Public Policy, Biodefense, or International Security?

The Schar School of Policy and Government is hosting a series of upcoming virtual information sessions for prospective master’s and PhD students. These interactive sessions offer a direct opportunity to learn about curriculum structure, career pathways in biodefense and policy, and the student experience at George Mason University.

From DC to Geneva: ELBI 2026 Fellows Conclude Year of Biosecurity Collaboration

By Kimberly Ma, PhD Candidate in Biodefense at George Mason University

Figure 1. ELBI 2026 fellows visited the United Nations in Geneva, Switzerland, as part of the program’s October workshop, which included meetings with leaders in global health and biological weapons disarmament.

The Johns Hopkins University Center for Health Security’s Emerging Leaders in Biosecurity Initiative has officially wrapped up its final workshop for its 2026 cohort of ELBI fellows! ELBI had three events in 2026: a workshop in DC in March, the ELBI research symposium in July, and a trip to Geneva in late October.

Fellows brought a wide range of sectors, experience, specialties, and home countries (this year’s fellows covered 5 different continents!), and the first workshop served as both an opportunity to start to get to know each other and a way to level-set so that all fellows had the foundational knowledge to engage in discussions. The July event was a fantastic display of the broad expertise and passions of the ELBI fellows’ network, as current and former fellows came together for a research symposium to present on their current efforts and discuss thoughts on future directions. For the most recent October event, fellows traveled to Geneva, where they met with renowned experts in the biodefense and biosecurity fields, including leadership members from the WHO and BWC ISU. It concluded with a tabletop exercise where fellows played major leadership members and had to decide how best to respond to and mitigate an evolving pandemic.

Biodefense PhD candidate Kimmy Ma was a member of the 2026 cohort, and she highly recommends that GMU Biodefense PhD and master’s students apply to ELBI in the future. “I am so grateful for all of the exposure to topic areas that I am less well-versed in, and for the immensely interesting and entertaining discussions that my cohort and I had at the formal programming. However, at the end of the day, my biggest takeaway was that ELBI’s value is in the people that it brings together. The knowledge that I now am part of a global network of people whose hearts are all in the right place gives me both comfort and motivation that I will be able to make a positive impact in the future — not by myself, but alongside fellow ELBIs and other passionate biosecurity folks.”


Avian Flu Reaches Oregon as Washington Cases Grow

By Margeaux Malone, Pandora Report Associate Editor

On November 10, Oregon confirmed its first case of highly pathogenic avian influenza (HPAI) H5 clade 2.3.4.4b in dairy cattle in Morrow County. The virus was first flagged on November 6 by Oregon State University through the state’s routine milk surveillance program, then confirmed by USDA’s National Veterinary Services Laboratories. The herd had consistently tested negative under the National Milk Testing Strategy before this detection and no other affected dairies have been identified. The farm is now quarantined with enhanced biosecurity measures while an epidemiological investigation takes place. Oregon is the 22nd state to report the virus in dairy herds, only about a month after neighboring Washington state reported its first dairy HPAI detection.

Although no human cases have been reported in Oregon at this time, the situation in Washington continues to progress. The state has had 41 confirmed HPAI cases in dairy cattle in the last 30 days, most in Yakima County. To date, county officials have reported three human infections and one death, a resident with underlying health conditions who was exposed to infected cattle. However, the United Farm Workers union claims the number of human cases is vastly underreported. The union stated that it has connected with several workers who are sick with avian flu-like symptoms ranging from mild respiratory illness and pinkeye to severe cough, fever, and bone pain, but have not been tested for the virus. It pointed to fear of immigration enforcement as one reason workers are reluctant to engage with public health agencies. “UFW staff are trying to support sick workers, but there are many barriers,” the union stated. “Workers with milder symptoms are reluctant to be tested or miss work because sick cattle still need care. Workers are very afraid of ICE-related retaliation if they don’t follow employer’s instructions.” Lack of sick leave and gaps in personal protective equipment training have also reportedly contributed to an increase in human cases. No human-to-human transmission has yet been reported, but farm workers remain one of the highest risk groups for contracting the virus due to their prolonged exposure to infected cattle.

Further Reading:


Chemical and Biological Security at the 2026 EU Non-Proliferation and Disarmament Conference

The EU Non-Proliferation and Disarmament Consortium held its annual conference on November 9-10, 2026, in Brussels, Belgium. Biodefense Program director, Professor Gregory Koblentz, spoke on the panel “Evolving Threats, Enduring Norms: Chemical and Biological Weapons in a Changing World,” about the current challenges facing the norm against chemical weapons and the Organization for the Prohibition of Chemical Weapons (OPCW), which represents the international legal embodiment of the norm. His talk was based on two recent articles, “Chemical Security is National Security” and “Cleaning Up Assad’s Toxic Legacy.” The other panelists were Emma Ross, Director of the Global Health Programme at Chatham House, who spoke about the convergence of challenges in global health, geopolitics, and international development assistance that is weakening global health security; Professor Margaret E. Kosal at the Sam Nunn School of International Affairs at Georgia Institute of Technology, who spoke about how policy-makers can better assess the risks and benefits of emerging technologies in the fields of chemistry and biology; and Ambassador Leonardo Bencini, an Italian diplomat who served as the president of the Ninth Review Conference of the Biological Weapons Conventions (BWC) and provided his insights into what to expect at the pivotal BWC meetings that will be occurring in Geneva in December. Together the panelists provided a comprehensive overview of some of the key challenges and opportunities facing the chemical and biological nonproliferation regimes considering recent developments in geopolitics and advances in science and technology. The panel was ably moderated by Tatyana Novossiolova, Senior Analyst at the Center for the Study of Democracy in Bulgaria and featured a lively Q&A session with the audience.


IN OTHER NEWS

Biological Weapons, AI & Biosecurity

Chemical & Nuclear Weapons

Emerging Infectious Diseases & Public Health

Science Policy & Research Funding

After NSCEB: What Comes Next for U.S. Biotech Policy

Tuesday, November 17 | 2:00 – 6:00 pm ET

From the National Security Commission on Emerging Biotechnology (NSCEB): “​The Commission’s authority ends December 31. What it built is the beginning. Carrying it forward takes Congress, industry and capital. In April 2025, the Commission called for $15 billion over five years to secure American leadership in biotechnology. Join Commission leadership, members of Congress, founders and investors for an afternoon on who carries that work into 2027.”

Link to register

Canadian Biosafety Guidelines: Risk Management for Dual-Use Potential in Life Science Research – Webinar

Thursday, November 26 | 1:00 – 2:00 pm ET

From the Public Health Agency of Canada: “Life science research drives breakthroughs that benefit society, but how can organizations and researchers ensure those advances are pursued responsibly? Join the Centre for Biosecurity for an upcoming webinar to learn about the new Canadian Biosecurity Guideline on Risk Management for Dual-Use Potential in Life Science Research. Participants will gain an overview of the newly published guideline, learn the importance of dual-use risk management, and explore practical approaches for identifying, assessing, and mitigating associated risks.”

Link to register

Gordon Research Seminar (GRS) on Chemical and Biological Defense

Saturday, February 27 – Sunday, February, 2027 | Ventura, CA

Held directly before the main Gordon Research Conference (see below), this two-day seminar, “Integrated Response Strategies for Complex Threats in Chemical and Biological Defense,” provides a unique forum for early-career researchers, doctoral students, and postdocs to present original work, discuss emerging threats, and build professional networks. Key topics include threat detection, characterization, and convergent approaches spanning in silico, in vitro, and in vivo models. The program features oral presentations, poster sessions, and a mentorship panel on “Career Pathways and Perspectives in Chemical and Biological Defense.” Abstract submission deadline for talk consideration is November 22, 2026; general applications close January 30, 2027.

Link to apply

Gordon Research Conference (GRC) on Chemical and Biological Defense

Sunday, February 28 – Friday, March 5, 2027 | Ventura, CA

Join international researchers, policy leaders, and scientists for a Gordon Research Conference, “The Convergence of In Silico, In Vitro, and In Vivo Models to Address the Divergent and Intersecting Profiles of Chemical and Biological Threats.” This five-day premier conference focuses on cutting-edge research in chemical and biological defense. Session topics include AI-accelerated science, agent-agnostic threat detection, attribution of CBRN events, medical countermeasure design, and biosecurity policy governance. Applications are due by January 31, 2027.

Link to apply

Leave a Reply